Trial Profile
Phase III trial of TV1001SR in the patients with systemic sclerosis
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 13 Jun 2017
Price :
$35
*
At a glance
- Drugs Sodium nitrite (Primary)
- Indications Systemic scleroderma
- Focus Registrational; Therapeutic Use
- Sponsors Soin Neuroscience
- 13 Jun 2017 New trial record
- 07 Jun 2017 According to a Soin Neuroscience media release, this trial is expected to begin within the next year.